Why the study?
Tricuspid regurgitation has prognostic implications, but isolated tricuspid valve surgery carries high mortality and is infrequently performed, creating an unmet clinical need.
Answers are grounded in this paper and cite their sources.
This review highlights emerging percutaneous therapeutic options for tricuspid regurgitation, addressing a significant unmet clinical need due to the high mortality associated with isolated tricuspid valve surgery.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Agricola et al. (2019) conducted a review in Tricuspid regurgitation. Percutaneous therapies (tricuspid valve repair or replacement) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: